Quadrivalent seasonal influenza VLP vaccine: Phase II started

Novavax began a single-blind, U.S. Phase II trial to evaluate 3 dose levels

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE